Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Aviragen Therapeutics Inc (NASDAQ:AVIR)

During the Trading Day
0.6667 +0.0417 / +6.67%
As of 3:57pm ET
Day’s Change
During After-Hours   Switch to standard view »
0.71 +0.0433 / +6.49%
Volume: 2.5K

Stock Price Forecast

The 3 analysts offering 12-month price forecasts for Aviragen Therapeutics Inc have a median target of 5.00, with a high estimate of 5.00 and a low estimate of 2.50. The median estimate represents a +649.96% increase from the last price of 0.67.

Analyst Recommendations

The current consensus among 3 polled investment analysts is to Hold stock in Aviragen Therapeutics Inc. This rating has held steady since March, when it was unchanged from a Hold rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
May 10

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 13.04%
Growthannually -37.95%


Growthquarterly -21.93%
Growthannually -27.24%
Key to the earnings and sales forecast charts.